Stay updated on Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Sign up to get notified when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.

Latest updates to the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check10 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed information about a clinical trial for dupilumab in asthma and the addition of a new version revision. The collaborators' information remains consistent, but the core content regarding the study's objectives and participant criteria has been deleted.SummaryDifference8%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.